onPoint Oncology
↗Hudson, OH, USA
onPoint Oncology is a leader in oncology reimbursement data and analytics, providing software solutions that help oncology practices and life sciences companies navigate complex access and reimbursement challenges. Their flagship product, focalPoint, enables real-time payer surveillance and revenue cycle management for physician-administered therapies, helping to optimize drug reimbursement and improve patient access to care.
In November 2020, onPoint Oncology was acquired by RxVantage, a digital platform connecting healthcare providers to educational resources and experts from life science companies. onPoint operates as a wholly-owned subsidiary of RxVantage, with its data and analytics capabilities integrated into the broader RxVantage ecosystem to support oncology care teams.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Oncology Reimbursement & Analytics
SIZE & FINANCIALS
Employees:1-50
Founded:2008
Ownership:subsidiary
Status:acquired
0
CORPORATE STRUCTURE
Parent Company:RxVantage
Acquired By:RxVantage (2020-11-01)
Key Partnerships:RxVantage (Parent Company)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Tracy L. Lewis - Founder and President
Roberta (Bobbi) Buell - Principal
LINKS
Website:onpointoncology.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of onPoint Oncology and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with onPoint Oncology. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.